GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neutra Corp (OTCPK:NTRR) » Definitions » Liabilities-to-Assets

Neutra (Neutra) Liabilities-to-Assets : 35.67 (As of Oct. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Neutra Liabilities-to-Assets?

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Neutra's Total Liabilities for the quarter that ended in Oct. 2023 was $0.96 Mil. Neutra's Total Assets for the quarter that ended in Oct. 2023 was $0.03 Mil. Therefore, Neutra's Liabilities-to-Assets Ratio for the quarter that ended in Oct. 2023 was 35.67.


Neutra Liabilities-to-Assets Historical Data

The historical data trend for Neutra's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neutra Liabilities-to-Assets Chart

Neutra Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Liabilities-to-Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.74 5.67 5.25 8.81 10.85

Neutra Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Liabilities-to-Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.29 10.85 15.98 24.81 35.67

Competitive Comparison of Neutra's Liabilities-to-Assets

For the Biotechnology subindustry, Neutra's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neutra's Liabilities-to-Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neutra's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Neutra's Liabilities-to-Assets falls into.



Neutra Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Neutra's Liabilities-to-Assets Ratio for the fiscal year that ended in Jan. 2023 is calculated as:

Liabilities-to-Assets (A: Jan. 2023 )=Total Liabilities/Total Assets
=0.814/0.075
=10.85

Neutra's Liabilities-to-Assets Ratio for the quarter that ended in Oct. 2023 is calculated as

Liabilities-to-Assets (Q: Oct. 2023 )=Total Liabilities/Total Assets
=0.963/0.027
=35.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neutra  (OTCPK:NTRR) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.


Neutra Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Neutra's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Neutra (Neutra) Business Description

Traded in Other Exchanges
N/A
Address
54 Sugar Creek Center Boulevard, Suite 200, Sugar Land, TX, USA, 77478
Neutra Corp is a development-stage company, which intends to market and participate in the nutraceutical space by bringing products derived from all natural and organic origins. Along with participating in the actual nutraceutical products, the company plans to research and bring new technology to the Nutraceutical space. Nutraceutical natural medicine is an alternative system that focuses on natural remedies and the body's vital ability to heal and maintain itself. It focuses on the areas of anti-aging, sleep disorders, pain management, and others. Geographically, all the activities are operated through the region of the United States.
Executives
Sydney Jim director, officer: CEO & Chairman 8875 HIDDEN RIVER PARKWAY, SUITE 300, TAMPA FL 34243